380222-94-6Relevant articles and documents
Route selection and process development of a multikilogram route to the inhaled A2a agonist UK-432,097
Ashcroft, Christopher P.,Dessi, Yann,Entwistle, David A.,Hesmondhalgh, Lynsey C.,Longstaff, Adrian,Smith, Julian D.
, p. 470 - 483 (2012/08/08)
This article describes the selection, process development, and scale-up of a synthetic route to a complex nucleoside analogue, the A2a agonist UK-432,097 (1), that culminated in the manufacture of over 25 kg of the API. The key steps in the process were (1) a stereoselective glycosidation reaction; (2) a scalable bleach-TEMPO oxidation; and (3) an unusual elevated temperature crystallization process for the final API. The problems that were encountered with the scale-up of the route together with how they were overcome are also presented.